Creatine for the Treatment of Amyotrophic Lateral Sclerosis - Contacts and Locations

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

This study has been completed.

Study NCT00070993. Last updated on August 3, 2006. Information provided by National Center for Complementary and Alternative Medicine (NCCAM)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00070993

Locations


United States, California
	California Pacific Medical Center
	San Francisco, California, United States, 94115

United States, Illinois
	Rush-Presbyterian St. Luke's Medical Center
	Chicago, Illinois, United States, 60612

United States, Kansas
	University of Kansas Medical Center
	Kansas City, Kansas, United States, 66160

United States, New Mexico
	University of New Mexico - Medical Center
	Albuquerque, New Mexico, United States, 87131

United States, Texas
	University of Texas Health and Science Center
	San Antonio, Texas, United States, 78284

United States, Virginia
	University of Virginia Health System
	Charlottesville, Virginia, United States, 22908

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators


Principal Investigator:	Jeffrey Rosenfeld, MD	Carolinas Medical Center